The Lancet Digital Health,
Год журнала:
2021,
Номер
3(3), С. e195 - e203
Опубликована: Янв. 19, 2021
There
has
been
a
surge
of
interest
in
artificial
intelligence
and
machine
learning
(AI/ML)-based
medical
devices.
However,
it
is
poorly
understood
how
which
AI/ML-based
devices
have
approved
the
USA
Europe.
We
searched
governmental
non-governmental
databases
to
identify
222
240
The
number
increased
substantially
since
2015,
with
many
being
for
use
radiology.
few
were
qualified
as
high-risk
Of
124
commonly
Europe,
80
first
One
possible
reason
approval
Europe
before
might
be
potentially
relatively
less
rigorous
evaluation
substantial
highlight
need
ensure
regulation
these
Currently,
there
no
specific
regulatory
pathway
or
recommend
more
transparency
on
are
regulated
enable
improve
public
trust,
efficacy,
safety,
quality
A
comprehensive,
publicly
accessible
database
device
details
Conformité
Européene
(CE)-marked
US
Food
Drug
Administration
needed.
arXiv (Cornell University),
Год журнала:
2019,
Номер
unknown
Опубликована: Янв. 1, 2019
Many
applications
of
machine
learning
require
a
model
to
make
accurate
pre-dictions
on
test
examples
that
are
distributionally
different
from
training
ones,
while
task-specific
labels
scarce
during
training.
An
effective
approach
this
challenge
is
pre-train
related
tasks
where
data
abundant,
and
then
fine-tune
it
downstream
task
interest.
While
pre-training
has
been
in
many
language
vision
domains,
remains
an
open
question
how
effectively
use
graph
datasets.
In
paper,
we
develop
new
strategy
self-supervised
methods
for
Graph
Neural
Networks
(GNNs).
The
key
the
success
our
expressive
GNN
at
level
individual
nodes
as
well
entire
graphs
so
can
learn
useful
local
global
representations
simultaneously.
We
systematically
study
multiple
classification
find
naive
strategies,
which
GNNs
either
or
nodes,
give
limited
improvement
even
lead
negative
transfer
tasks.
contrast,
avoids
improves
generalization
significantly
across
tasks,
leading
up
9.4%
absolute
improvements
ROC-AUC
over
non-pre-trained
models
achieving
state-of-the-art
performance
molecular
property
prediction
protein
function
prediction.
The Lancet Digital Health,
Год журнала:
2021,
Номер
3(3), С. e195 - e203
Опубликована: Янв. 19, 2021
There
has
been
a
surge
of
interest
in
artificial
intelligence
and
machine
learning
(AI/ML)-based
medical
devices.
However,
it
is
poorly
understood
how
which
AI/ML-based
devices
have
approved
the
USA
Europe.
We
searched
governmental
non-governmental
databases
to
identify
222
240
The
number
increased
substantially
since
2015,
with
many
being
for
use
radiology.
few
were
qualified
as
high-risk
Of
124
commonly
Europe,
80
first
One
possible
reason
approval
Europe
before
might
be
potentially
relatively
less
rigorous
evaluation
substantial
highlight
need
ensure
regulation
these
Currently,
there
no
specific
regulatory
pathway
or
recommend
more
transparency
on
are
regulated
enable
improve
public
trust,
efficacy,
safety,
quality
A
comprehensive,
publicly
accessible
database
device
details
Conformité
Européene
(CE)-marked
US
Food
Drug
Administration
needed.